Nandita Bagchi, Rashmi N. Nagdeve, Abhishek Walke, S. Chatterjee
{"title":"Mauriac Syndrome in a Patient of Type 1 Diabetes Mellitus","authors":"Nandita Bagchi, Rashmi N. Nagdeve, Abhishek Walke, S. Chatterjee","doi":"10.25259/vjim_6_2022","DOIUrl":null,"url":null,"abstract":"Mauriac syndrome is a metabolic complication of poor glycaemic control in Type 1 DM patients, unique to children, characterised by growth failure, short stature, delayed puberty, Cushingoid features, and marked hepatomegaly from massive deposition of glycogen. It is probably due to a combination of factors including inadequate glucose uptake and utilisation in the tissues, decreased insulin-like growth factor-1 and growth hormone levels, impaired bioactivity of these hormones, a circulating hormone inhibitor, resistant or defective hormone receptors, insulin deficiency, and poor glycaemic control. This syndrome is rarely seen nowadays because of better treatment modalities.","PeriodicalId":232453,"journal":{"name":"Vidarbha Journal of Internal Medicine","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vidarbha Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/vjim_6_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Mauriac syndrome is a metabolic complication of poor glycaemic control in Type 1 DM patients, unique to children, characterised by growth failure, short stature, delayed puberty, Cushingoid features, and marked hepatomegaly from massive deposition of glycogen. It is probably due to a combination of factors including inadequate glucose uptake and utilisation in the tissues, decreased insulin-like growth factor-1 and growth hormone levels, impaired bioactivity of these hormones, a circulating hormone inhibitor, resistant or defective hormone receptors, insulin deficiency, and poor glycaemic control. This syndrome is rarely seen nowadays because of better treatment modalities.